作为单剂量治疗性抗疟疾药物的原产品优化
Amrendra Kumar1, Yuexin Li2, Xiaowei Zhang2
1Department of Chemistry, Portland State University, Portland, Oregon 97201, United States.
Journal of medicinal chemistry
|November 18, 2025
概括
合成了新的原始类比物来对抗耐药疟疾. 化合物PG102在小鼠模型中显示出强烈的口服疗效,以及对具有低毒性的耐药疟疾菌株的活性.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 耐药疟疾需要具有独特机制的新型抗疟疾药物.
- 现有的治疗方法面临着新出现的抗药性挑战.
- 多阶段活性和良好的耐受性是新抗疟疾药物的关键要求.
研究的目的:
- 设计和合成新型原产品类似物作为潜在的抗疟疾药物.
- 识别具有广泛活动阶段和有利安全概况的化合物.
- 解决对抗耐药菌株有效的新抗疟疾药物的迫切需要.
主要方法:
- 系统修改原始脚手架的B和C环.
- 合成了54种新的原产品类似物.
- 在 *Plasmodium yoelii* 和 *Plasmodium berghei* 的小鼠模型中进行了体内疗效测试.
- 在体外测试对抗抗美西宁耐药的 *Plasmodium falciparum* 菌株.
- 基因毒性和心脏毒性分析.
主要成果:
- 化合物PG102 (类型6) 在红细胞疟疾模型中显示出治疗性口服疗效.
- PG102提供了对肝脏阶段感染的保护,并保留了对抗耐药P. falciparum*的效力.
- 该化合物具有中等的杀虫特征,具有低的基因毒性和心脏毒性潜力.
- 在原始类中首次证明了强大的单剂量抗疟疾疗效.
结论:
- PG102是下一代抗疟疾药物开发的有希望的化合物.
- 原始的脚手架可以有效地修改,以产生强大的抗疟疾药物.
- 由于其有效性和安全性,PG102的进一步开发需要进行调查.
更多相关视频
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
12.5K
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.8K
相关概念视频
01:30Prodrugs
3.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.8K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K